Literature DB >> 9672902

D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene.

M Laruelle1, J Gelernter, R B Innis.   

Abstract

Alcoholism and substance abuse have been associated with a polymorphism in a noncoding region of the D2 receptor gene (the A1 allele of the Taq1 'A' system) in several, but not all studies. In addition, the presence of the A1 allele has been associated with lower density of D2 receptors in the caudate nucleus in one postmortem study. If the Taq1 'A1' allele is in linkage disequilibrium with a mutation that decreases the expression of the D2 receptor gene, it is conceivable that subjects with the A1 allele might be predisposed to behaviors which stimulate dopamine transmission, such as alcoholism or substance abuse. In this study, we attempted to confirm the association between the A1 allele and lower D2 receptor density, and explored a possible association between the B1 allele and D2 receptor expression. Genotypes at the Taq1 'A' and 'B' systems were determined in 70 subjects who underwent in vivo measurement of D2 receptors-binding potential with single photon emission computerized tomography (SPECT) and the selective dopamine D2 receptor radiotracer [123I]IBZM. [123I]IBZM-binding potential was identical in A1 carriers (i.e., subjects heterozygous or homozygous for that allele) (230 +/- 85 ml g-1, n = 27) and A1 noncarriers (231 +/- 70 ml g-1, n = 43). Similarly, we found no effect of the B1 allele on [123I]IBZM-binding potential. In conclusion, the results of this study failed to replicate the previously reported association between A1 allele and lower D2 receptor expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672902     DOI: 10.1038/sj.mp.4000343

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  37 in total

1.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

2.  Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults.

Authors:  Guang Guo; Michael E Roettger; Jean C Shih
Journal:  Hum Genet       Date:  2006-10-31       Impact factor: 4.132

Review 3.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

4.  Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.

Authors:  Arthur L Brody; Mark A Mandelkern; Richard E Olmstead; David Scheibal; Emily Hahn; Sharon Shiraga; Eleanor Zamora-Paja; Judah Farahi; Sanjaya Saxena; Edythe D London; James T McCracken
Journal:  Arch Gen Psychiatry       Date:  2006-07

5.  Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study.

Authors:  Pushplata Prasad; Atul Ambekar; Meera Vaswani
Journal:  BMC Med Genet       Date:  2010-02-11       Impact factor: 2.103

6.  Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.

Authors:  Sarah A Eisenstein; Ryan Bogdan; Latisha Love-Gregory; Nadia S Corral-Frías; Jonathan M Koller; Kevin J Black; Stephen M Moerlein; Joel S Perlmutter; Deanna M Barch; Tamara Hershey
Journal:  Synapse       Date:  2016-06-17       Impact factor: 2.562

7.  The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women.

Authors:  Jameason D Cameron; Marie-Ève Riou; Frédérique Tesson; Gary S Goldfield; Rémi Rabasa-Lhoret; Martin Brochu; Éric Doucet
Journal:  Appetite       Date:  2012-09-29       Impact factor: 3.868

8.  Individual differences in dopamine D2 receptor availability correlate with reward valuation.

Authors:  Linh C Dang; Gregory R Samanez-Larkin; Jaime J Castrellon; Scott F Perkins; Ronald L Cowan; David H Zald
Journal:  Cogn Affect Behav Neurosci       Date:  2018-08       Impact factor: 3.282

9.  Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity.

Authors:  Lisa M Davis; Michael Michaelides; Lawrence J Cheskin; Timothy H Moran; Susan Aja; Paul A Watkins; Zhengtong Pei; Carlo Contoreggi; Karen McCullough; Bruce Hope; Gene Jack Wang; Nora D Volkow; Panayotis K Thanos
Journal:  Neuroendocrinology       Date:  2008-11-04       Impact factor: 4.914

10.  Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients.

Authors:  Zsofia Nemoda; Karlen Lyons-Ruth; Anna Szekely; Eszter Bertha; Gabor Faludi; Maria Sasvari-Szekely
Journal:  Behav Brain Funct       Date:  2010-01-12       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.